Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Auteur principal: | Shawn, Ibna Hasan |
---|---|
Autres auteurs: | Jamiruddin, Mohd. Raeed |
Format: | Thèse |
Langue: | English |
Publié: |
Brac University
2024
|
Sujets: | |
Accès en ligne: | http://hdl.handle.net/10361/23931 |
Documents similaires
-
A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
par: Chakraborty, Anupama
Publié: (2024) -
Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
par: Onanna, Kazi
Publié: (2024) -
Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
par: Rahman, Towsifur
Publié: (2024) -
A review on combinatorial therapies in Melanoma
par: Ahmmed, Md. Kawsar
Publié: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
par: Khandker, Tahia Anjum
Publié: (2024)